(Q38105320)

28 August 2017

Galectins as cancer biomarkers (English)

1 reference

28 August 2017

0 references

Pratima Nangia-Makker

series ordinal

2

0 references

author name string

Vitaly Balan

series ordinal

1

1 reference

PMC publication ID

3645499

28 August 2017

Avraham Raz

series ordinal

3

1 reference

28 August 2017

1 April 2010

1 reference

28 August 2017

1 reference

28 August 2017

2

1 reference

28 August 2017

2

1 reference

28 August 2017

592-610

1 reference

Creative Commons Attribution 4.0 International

28 August 2017

start time

20 April 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Roles of galectins in infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Regulation of prostate cancer progression by galectin-3

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Racial disparity in breast cancer and functional germ line mutation in galectin-3 (rs4644): a pilot study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Low expression of Bax predicts poor prognosis in resected non-small cell lung cancer patients with non-squamous histology

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Biomarker panel diagnosis of thyroid cancer: a critical review

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Epidermal growth factor receptor expression in serous ovarian carcinoma: an immunohistochemical study with galectin-3 and cyclin D1 and outcome

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Galectin-3 cleavage: a novel surrogate marker for matrix metalloproteinase activity in growing breast cancers.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

An emerging role for galectins in tuning the immune response: lessons from experimental models of inflammatory disease, autoimmunity and cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

A distinct molecular profile associated with mucinous epithelial ovarian cancer.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Galectin-3: an open-ended story

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Galectin-9 as a prognostic factor with antimetastatic potential in breast cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Alterations in galectin-3 expression and distribution correlate with breast cancer progression: functional analysis of galectin-3 in breast epithelial-endothelial interactions.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Galectin-3 and cancer (Review).

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Cell surface overexpression of galectin-3 and the presence of its ligand 90k in the blood plasma as determinants in colon neoplastic lesions

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Galectin-4 in normal tissues and cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Human galectin-8 isoforms and cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Increased expression of the LGALS3 (Galectin 3) gene in human non–small‐cell lung cancer

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Upregulation of galectins-1 and -3 in human colon cancer and their role in regulating cell migration

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Immunohistochemical expression of the intracellular component of galectin-8 in squamous cell metaplasia of the bronchial epithelium in neoplastic and benign processes

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Down-regulation of galectin-3 suppresses tumorigenicity of human breast carcinoma cells.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Galectin-3, a beta-galactoside-binding animal lectin, is a marker of anaplastic large-cell lymphoma.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Galectins. Structure and function of a large family of animal lectins

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Galectin-3 increases gastric cancer cell motility by up-regulating fascin-1 expression

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Differential expression of galectins in normal, benign and malignant prostate epithelial cells: silencing of galectin-3 expression in prostate cancer by its promoter methylation

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Galectin-3: differential expression between small-cell and non-small-cell lung cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Expression of extracellular matrix markers in benign meningiomas

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Decreased galectin-3 expression in prostate cancer

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Concentrations of galectin-3 in the sera of normal controls and cancer patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Induction of tumorigenicity by galectin-3 in a nontumorigenic human breast-carcinoma cell-line.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Evaluation of the prognostic significance of serum galectin-3 in American Joint Committee on Cancer stage III and stage IV melanoma patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Detection of new diagnostic markers in pathology by focus on growth-regulatory endogenous lectins. The case study of galectin-7 in squamous epithelia.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Expression of galectin-3-reactive ligands in squamous cancer and normal epithelial cells as a marker of differentiation.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Expression of galectins in head and neck squamous cell carcinoma

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Differential expression of galectin-1 and galectin-3 in thyroid tumors. Potential diagnostic implications

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Increased serum 90K and Galectin-3 expression are associated with advanced stage and a worse prognosis in diffuse large B-cell lymphomas.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Molecular phenotyping of thyroid tumors identifies a marker panel for differentiated thyroid cancer diagnosis.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Galectin-3: a useful biomarker for differential diagnosis of brain tumors

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Combined immunostaining with galectin-3, fibronectin-1, CITED-1, Hector Battifora mesothelial-1, cytokeratin-19, peroxisome proliferator-activated receptor-{gamma}, and sodium/iodide symporter antibodies for the differential diagnosis of non-medulla

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Crystal structure of the galectin-9 N-terminal carbohydrate recognition domain from Mus musculus reveals the basic mechanism of carbohydrate recognition.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

High serum galectin-3 in advanced melanoma: preliminary results

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Expression of galectin-3 in primary and metastatic melanoma: immunohistochemical studies on human lesions and nude mice xenograft tumors.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Galectin-3: cellular distribution and correlation with WHO-grade in human gliomas

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Galectin-3 and galectin-3-binding site expression in human adult astrocytic tumours and related angiogenesis

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Galectin-3 is a presurgical marker of human thyroid carcinoma.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

Expression of an endogenous galactose-binding lectin correlates with neoplastic progression in the colon.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3645499

31 August 2018

1 reference

https://api.crossref.org/works/10.3390%2FCANCERS2020592

Galectin-3 Expression Is Associated with Tumor Progression and Pattern of Sun Exposure in Melanoma

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.3390%2FCANCERS2020592

Galectin-3 – an emerging prognostic indicator in advanced head and neck carcinoma

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.3390%2FCANCERS2020592

Galectin-3 expression in non-small cell lung carcinoma

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.3390%2FCANCERS2020592

Galectin-3 expression in human breast carcinoma: correlation with cancer histologic grade

21 January 2018

1 reference

12 December 2020

Decreased expression of galectin-3 is associated with progression of human breast cancer

1 reference

12 December 2020

Clinicopathological significance of galectin-3 expression in ductal adenocarcinoma of the pancreas

1 reference

12 December 2020

Diagnostic utility of galectin-3 and CD26/DPPIV as preoperative diagnostic markers for thyroid nodules

1 reference

12 December 2020

Alteration of the cytoplasmic/nuclear expression pattern of galectin-3 correlates with prostate carcinoma progression

1 reference

12 December 2020

Serum level of galectin-3 in human bladder cancer

1 reference

12 December 2020

Galectin-3 in urine of cancer patients: stage and tissue specificity

1 reference

12 December 2020

Expression of cathepsin D and galectin 3 in tubular carcinomas of the breast

1 reference

12 December 2020

Expression of Galectin-3 and Galectin-7 in thyroid malignancy as potential diagnostic indicators

1 reference

12 December 2020

Cytokeratin 19 and galectin-3 immunohistochemistry in the differential diagnosis of solitary thyroid nodules

1 reference

12 December 2020

The role of microvascularization and growth/adhesion-regulatory lectins in the prognosis of non-small cell lung cancer in stage II

1 reference

12 December 2020

Increased expression of galectin-3 in primary gastric cancer and the metastatic lymph nodes

1 reference

12 December 2020

Localization of galectin-3 in normal and diseased pancreatic tissue

1 reference

12 December 2020

Involvement of galectin-3 expression in colorectal cancer progression and metastasis

1 reference

12 December 2020

Expression of the 67-kD laminin receptor, galectin-1, and galectin-3 in advanced human uterine adenocarcinoma

1 reference

12 December 2020

Galectin-3 is not useful in thyroid FNA

1 reference

12 December 2020

Galectin-3 Upregulation During Tumor Progression in Head and Neck Cancer

1 reference

12 December 2020

Distinguishing benign from malignant thyroid lesions: galectin 3 as the latest candidate

1 reference

12 December 2020

Potential diagnostic markers in nodular lesions of the thyroid gland: an immunohistochemical study

1 reference

12 December 2020

Prognostic significance of endogenous adhesion/growth-regulatory lectins in lung cancer

1 reference

12 December 2020

Galectin-3 is not an universal marker of malignancy in thyroid nodular disease in children and adolescents

1 reference

12 December 2020

Expression of Po66-CBP, a galectin-8, in different types of primary and secondary broncho-pulmonary tumors

1 reference

12 December 2020

Expression of a 31-kDa lactoside-binding lectin in normal human gastric mucosa and in primary and metastatic gastric carcinomas

1 reference

12 December 2020

Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms

1 reference

12 December 2020

Galectin-1 and galectin-3 expression in human bladder transitional-cell carcinomas

1 reference

12 December 2020

Galectin-1 and galectin-3 expression in human prostate tissue and prostate cancer

1 reference

12 December 2020

Serum Galectin-1 and Galectin-3 Levels in Benign and Malignant Nodular Thyroid Disease

1 reference

12 December 2020

Galectin-3, a marker of well-differentiated thyroid carcinoma, is expressed in thyroid nodules with cytological atypia

1 reference

12 December 2020

Galectin-3, an endogenous lectin, as a tool for monitoring cell differentiation in head and neck carcinomas with implications for lectin-glycan functionality

1 reference

12 December 2020

Increased galectin-3 expression in gastric cancer: correlations with histopathological subtypes, galactosylated antigens and tumor cell proliferation

1 reference

12 December 2020

Comparative analysis of galectins in primary tumors and tumor metastasis in human pancreatic cancer

1 reference

12 December 2020

Diagnostic value of galectin-3 as a marker for malignancy in follicular patterned thyroid lesions

1 reference

12 December 2020

Galectin-3 expression is a potent prognostic marker in colorectal cancer

1 reference

12 December 2020

Lack of Expression of Galectin-3 Is Associated With a Poor Outcome in Node-Negative Patients With Laryngeal Squamous-Cell Carcinoma

1 reference

12 December 2020

The determination of the levels of circulating galectin-1 and -3 in HNSCC patients could be used to monitor tumor progression and/or responses to therapy

1 reference

12 December 2020

Increased expression of galectin-1 in carcinoma-associated stroma predicts poor outcome in prostate carcinoma patients

1 reference

12 December 2020

Identifiers

DOI

10.3390/CANCERS2020592

1 reference

28 August 2017

1 reference

PMC publication ID

3645499

28 August 2017

PubMed publication ID

23658855

1 reference

PMC publication ID

3645499